Biosplice Therapeutics
PrivateLast Round
VC Round
Apr 15, 2021
Est. Valuation
$12.44B
Total Funding Raised
$878M
Company Overview
Biosplice Therapeutics is a biotechnology company that develops tissue-level therapeutic drugs for osteoarthritis, oncology, and other degenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosplice Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biosplice Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 15, 2021 | ||||
| Series A Extension | Aug 6, 2018 | ||||
| Series A | Apr 13, 2016 |
Key People
Founding team and executive leadership
Biosplice Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | VC Round |
| Polar Light Ventures | Series A Extension |
| Eventide Funds | VC Round |
| Ingka Investments | Series A |
| aMoon | VC Round |
| Starling Group | Series A Extension |
| Vickers Venture Partners | Early Funding, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2021
$120M round with participation from Eventide Funds and Verition Fund Management.
Biosplice Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Biosplice Therapeutics's valuation, stock price, and market status.